Based on the fact that smokers respond better than non-smoker in the treatment by not only NSCLC but also urothelial carcinoma, and head and neck cancer by PD-1/PD-L1 inhibitors, we assume that smoking alters features of the cell surface in the whole body. The gene discussed is CD274; the disease is head and neck cancer.